With more than 90 peer-reviewed in-vivo trials, Mycosorb’s mode of action is supported by 20 PhD and 22 Master’s projects and several patents. Mycosorb is part of the Alltech Mycotoxin Management programme, which assists not only with managing mycotoxins through the feed chain, but also with detecting and addressing the risks caused by more than 37 types of mycotoxins.
Founded in 1980 by Irish entrepreneur and scientist Dr Pearse Lyons, Alltech improves the health and performance of people, animals and plants through natural nutrition and scientific innovation. Its mission is carried out by more than 4200 team members who adhere to the company’s guiding ACE principle, seeking the benefit of Animals, Consumers and the Environment in all endeavours.
Headquartered just outside Lexington, Kentucky, Alltech has a strong presence around the world, doing business in 128 countries. For further information, visit www.alltech.com.
